ABACAVIR SULFATE (ZIAGEN)

Course overview

Abacavir (ABC) is a nucleoside reverse transcriptase inhibitor (NRTI) that is U.S. FDA-approved to treat HIV infection in patients ≥ 3 months in combination with other antiretroviral agents as part of highly-active antiretroviral therapy (HAART). This continuing education module is designed to give the reader/learner an increased understanding of abacavir. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.